Jun Tang BEng, MSc, PhD

Dr. Jun Tang joined the Clinical Accelerator program in January 2017 as a senior research analyst, where he has been leading the intelligence support to novel immuno-oncology (IO) combination therapy clinical trials. In this program, Jun analyzes the landscape of the clinical IO development, identifies promising IO combination therapies, collaborates with leading clinical investigators to test these combinations in clinical trials, supports due diligence requests from nonprofit and industry partners, and also publishes analyses in leading academic journals. To date, work from Dr. Tang at CRI has been published in Annals of Oncology and Nature Reviews Drug Discovery. Dr. Jun Tang received a PhD in translational medicine from Icahn School of Medicine at Mount Sinai and completed a research fellowship in Memorial Sloan Kettering Cancer Center.